Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 12/20 | 0.45 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 10/20 | 0.44 |
| ▸ | LMNA | P02545 | 3/20 | 0.44 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 4/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.41 |
| ▸ | GLA | P06280 | 2/20 | 0.41 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | CASP7 | P55210 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.40 |
| ▸ | CA12 | O43570 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 2/20 | 0.40 |
| ▸ | CA2 | P00918 | 2/20 | 0.40 |
| ▸ | CA7 | P43166 | 2/20 | 0.40 |
| ▸ | CA9 | Q16790 | 2/20 | 0.40 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2128862 | 0.85 | ALDH1A1 (0.49) | KDM4EKMT2AALDH1A1LMNAMAPT | |
| SCHEMBL820141 | 0.83 | KDM4E (0.55) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL29699657 | 0.83 | KDM4E (0.55) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL873754 | 0.81 | TSHR (0.50) | KDM4EKMT2AALDH1A1LMNAMAPT | |
| SCHEMBL4885782 | 0.79 | ALDH1A1 (0.43) | KDM4EKMT2AALDH1A1LMNAHSD17B10 | |
| SCHEMBL5834949 | 0.79 | KDM4E (0.50) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL293611 | 0.78 | KDM4E (0.55) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL293610 | 0.78 | KDM4E (0.53) | KDM4EALDH1A1LMNAMAPTHPGD | |
| SCHEMBL2160586 | 0.77 | MAPT (0.56) | KMT2AALDH1A1MAPTTSHRMAPK1 | |
| Pentane SCHEMBL819070 | 0.77 | ALDH1A1 (0.49) | KDM4EKMT2AALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION | 2025-07-31 | — | — | US | claimed |
| EP-4479092-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | Purdue Research Foundation (US) | 2024-12-25 | — | — | EP | claimed |
| WO-2023154171-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION (US) | 2023-08-17 | — | — | WO | claimed |
| US-20180311278-A1 | PHARMACEUTICAL PREPARATION FOR DELIVERY OF POROUS MATERIAL TO LARGE INTESTINE OR LOWER PART OF SMALL INTESTINE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-11-01 | — | — | US | claimed |
| EP-3369424-A1 | POROUS MATERIAL FORMULATION FOR DELIVERY TO LARGE INTESTINE OR LOWER SMALL INTESTINE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-09-05 | — | — | EP | claimed |
| EP-2827900-B1 | AMORPHOUS SOLID DISPERSION FOR USE IN THE TREATMENT OF BRAIN CANCER | ARRAY BIOPHARMA INC (US) | 2018-03-21 | — | — | EP | claimed |
| EP-2765990-B1 | SOLID DISPERSION | ARRAY BIOPHARMA INC (US) | 2017-09-06 | — | — | EP | claimed |
| EP-1399190-B1 | PHARMACEUTICAL COMPOSITIONS COMPRISING LOW-SOLUBILITY AND ACID-SENSITIVE DRUGS AND NEUTRALIZED ACIDIC POLYMERS | BEND RES INC (US) | 2010-09-08 | — | — | EP | claimed |
| EP-4663198-A1 | COMPOSITION CONTAINING CYCLIC PEPTIDE COMPOUND AND SURFACTANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-12-17 | — | — | EP | disclosed |
| US-20250302912-A1 | COMPOSITION INCLUDING PEPTIDE COMPOUND AND SURFACTANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-10-02 | — | — | US | disclosed |
| EP-4609875-A2 | COMPOSITION CONTAINING PEPTIDE COMPOUND AND SURFACTANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-09-03 | — | — | EP | disclosed |
| EP-4603546-A1 | SOLID DISPERSION CONTAINING SUBSTANCE TO BE DISPERSED, PHARMACEUTICAL COMPOSITION CONTAINING SAME, AND PRODUCTION METHODS THEREFOR | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2025-08-20 | — | — | EP | disclosed |
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | PURDUE RESEARCH FOUNDATION | 2025-07-31 | — | — | US | disclosed |
| EP-4166133-B1 | COMPOSITION CONTAINING PEPTIDE COMPOUND AND SURFACTANT | CHUGAI PHARMACEUTICAL CO LTD (JP) | 2025-07-23 | — | — | EP | disclosed |
| EP-4166133-A1 | COMPOSITION CONTAINING PEPTIDE COMPOUND AND SURFACTANT | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2023-04-19 | — | — | EP | disclosed |
| CN-112770750-A | Solid dispersion of hydantoin derivative | 中外制药株式会社 | 2021-05-07 | — | — | CN | disclosed |
| WO-2020027011-A1 | SOLID DISPERSION OF HYDANTOIN DERIVATIVE | 中外製薬株式会社 | 2020-02-06 | — | — | WO | disclosed |
| CN-110636845-A | Amorphous form and solid dispersion of rumepilone p-toluenesulfonate | 雷迪博士实验室有限公司 | 2019-12-31 | — | — | CN | disclosed |
| US-20180311278-A1 | PHARMACEUTICAL PREPARATION FOR DELIVERY OF POROUS MATERIAL TO LARGE INTESTINE OR LOWER PART OF SMALL INTESTINE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-11-01 | — | — | US | disclosed |
| EP-3369424-A1 | POROUS MATERIAL FORMULATION FOR DELIVERY TO LARGE INTESTINE OR LOWER SMALL INTESTINE | DAIICHI SANKYO COMPANY, LIMITED (JP) | 2018-09-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250242031-A1 | POLYMER SALTS FOR IMPROVED DRUG DELIVERY FROM AMORPHOUS SOLID DISPERSIONS | SRI, SYNGR2, PSD | KDM4E 835/4885KMT2A 1269/4885ALDH1A1 3898/4885 |
| US-20250302912-A1 | COMPOSITION INCLUDING PEPTIDE COMPOUND AND SURFACTANT | PCTP, CETP, PLTP | KDM4E 4257/4885KMT2A 4487/4885ALDH1A1 4623/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.